Evidence map›Paper›PMID 41713572›Full record

ArticleThe Journal of biological chemistry2026

Transcriptome-guided discovery and active-site gatekeeper engineering of a Viola arcuata asparaginyl ligase with superior catalytic performance.

Qiongyan Zou, Yujiao Yan, Xinglei Zou, Peng Jiang, Jiongwen Qin, Xue Tang, Fawei He, Dongting Zhangsun, Sulan Luo, Yong Wu

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Qiongyan ZouGuangxi Key Laboratory of Special Biomedicine, School of Medicine, Guangxi University, Nanning, China.
Yujiao YanGuangxi Key Laboratory of Special Biomedicine, School of Medicine, Guangxi University, Nanning, China.
Xinglei ZouGuangxi Key Laboratory of Special Biomedicine, School of Medicine, Guangxi University, Nanning, China.
Peng JiangGuangxi Key Laboratory of Special Biomedicine, School of Medicine, Guangxi University, Nanning, China.
Jiongwen QinGuangxi Key Laboratory of Special Biomedicine, School of Medicine, Guangxi University, Nanning, China.
Xue TangGuangxi Key Laboratory of Special Biomedicine, School of Medicine, Guangxi University, Nanning, China.
Fawei HeGuangxi Key Laboratory of Special Biomedicine, School of Medicine, Guangxi University, Nanning, China.
Dongting ZhangsunGuangxi Key Laboratory of Special Biomedicine, School of Medicine, Guangxi University, Nanning, China.
Sulan LuoGuangxi Key Laboratory of Special Biomedicine, School of Medicine, Guangxi University, Nanning, China. Electronic address: sulan2g021@xu.edu.cn.
Yong WuGuangxi Key Laboratory of Special Biomedicine, School of Medicine, Guangxi University, Nanning, China. Electronic address: wuyong@gxu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Peptide macrocyclization by ligase-type asparaginyl endopeptidases (AEPs) underpins many emerging applications in peptide and protein engineering, yet only a few recombinant ligases currently offer suitable catalytic performance and operational robustness. Here we characterize VaPAL2, a previously unreported AEP from Viola arcuata, and show that its activity can be substantially enhanced through a single gatekeeper substitution. The engineered variant, VaPAL2(I244A), functions as a highly efficient peptide ligase, displaying rapid macrocyclization of GN-type substrates, strong ligation bias on branched sequences, and markedly improved tolerance to organic cosolvents such as 20% DMSO. Notably, VaPAL2(I244A) retains its high activity at near-neutral pH, making it compatible with preparative and protein-compatible conditions. Structural modeling indicates that the I244A substitution modestly widens the S1'-S2 substrate corridor, facilitating nucleophile entry while preserving the catalytic architecture. Together, these findings establish VaPAL2(I244A) as a new, robust macrocyclase that matches or exceeds the performance of widely used recombinant AEP ligase benchmarks under standardized conditions and meaningfully expands the enzymatic toolbox available for chemical biology and peptide engineering.

Indexed as

Cysteine EndopeptidasesLigasesProtein EngineeringAsparaginyl EndopeptidaseBiocatalysisCatalytic DomainModels, MolecularAsparaginyl EndopeptidaseCysteine EndopeptidasesLigasesasparaginyl endopeptidasegatekeeper engineeringmacrocyclizationpeptide ligaseViola arcuata

Identifiers

PMID41713572
PMCPMC12995904

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.